NCT02589457View on ClinicalTrials.gov

Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Chronic Hepatitis B
Interventions
DRUG

CKD-390

Tenofovir Disoproxil Aspartate 1T PO

DRUG

Viread® tablet

Tenofovir Disoproxil Fumarate 1T PO

Trial Locations (1)

301-721

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY